Off-Target Alterations Drive Resistance to TRK Inhibitors in Some Cancers

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-133
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Resistance to Antibiotics Mediated by Target Alterations

Science
MultidisciplinaryPhilosophy of ScienceHistory
1994English

Larotrectinib OK'd for Cancers With TRK Fusions

Cancer Discovery
Oncology
2018English

Corrigendum To: Off‐target Inhibition by Active Site‐targeting SHP 2 Inhibitors

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2019English

Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2014English

Combating Acquired TRK Inhibitor Resistance

Cancer Discovery
Oncology
2019English

Genomic Alterations in Mucins Across Cancers

Oncotarget
Oncology
2017English

Target-Site Resistance to Neonicotinoids

Journal of Chemical Biology
BiochemistryCell BiologyBiophysics
2014English

PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Combining Targeted Drugs to Overcome and Prevent Resistance of Solid Cancers With Some Stem-Like Cell Features

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy